These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2247371

  • 1. Immunocytochemical evaluation of neoplastic and non-neoplastic breast diseases with Mab A-80.
    Koukoulis GK, Shin SS, Gould VE, Jao W, Gooch GT, Manderino GL, Rittenhouse HG, Tomita JT.
    Pathol Res Pract; 1990 Aug; 186(4):439-49. PubMed ID: 2247371
    [Abstract] [Full Text] [Related]

  • 2. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
    Gould VE, Koukoulis GK, Jansson DS, Nagle RB, Franke WW, Moll R.
    Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
    [Abstract] [Full Text] [Related]

  • 3. Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80.
    Shin SS, Gould VE, Gould JE, Warren WH, Gould KA, Yaremko ML, Manderino GL, Rittenhouse HG, Tomita JT, Jansson DS.
    APMIS; 1989 Dec; 97(12):1053-67. PubMed ID: 2611021
    [Abstract] [Full Text] [Related]

  • 4. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE, Mosquera JM, Leykauf K, Gattuso P, Dürst M, Alonso A.
    Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP, Nicosia RF.
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [Abstract] [Full Text] [Related]

  • 10. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
    Koukoulis GK, Howeedy AA, Korhonen M, Virtanen I, Gould VE.
    J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
    [Abstract] [Full Text] [Related]

  • 11. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A, Arkadopoulos N, Gennatas C, Michalaki V, Frangou-Plegmenou M, Chatzipantelis P.
    Tumori; 2010 Apr; 96(6):978-84. PubMed ID: 21388062
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
    Pellegrino MB, Asch BB, Connolly JL, Asch HL.
    Cancer Res; 1988 Oct 15; 48(20):5831-6. PubMed ID: 2458830
    [Abstract] [Full Text] [Related]

  • 13. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N, Mylonas I, Kunert-Keil C, Briese V, Janni W, Gerber B, Friese K, Jeschke U.
    Anticancer Res; 2005 Oct 15; 25(3A):1761-4. PubMed ID: 16033096
    [Abstract] [Full Text] [Related]

  • 14. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R, Mitze M, Frixen UH, Birchmeier W.
    Am J Pathol; 1993 Dec 15; 143(6):1731-42. PubMed ID: 8256859
    [Abstract] [Full Text] [Related]

  • 15. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
    Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG.
    Cancer; 1996 Mar 15; 77(6):1079-88. PubMed ID: 8635127
    [Abstract] [Full Text] [Related]

  • 16. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
    Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C.
    Am J Surg Pathol; 2001 Aug 15; 25(8):1054-60. PubMed ID: 11474290
    [Abstract] [Full Text] [Related]

  • 17. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
    Dalal P, Shousha S.
    Mod Pathol; 1995 May 15; 8(4):413-6. PubMed ID: 7567941
    [Abstract] [Full Text] [Related]

  • 18. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
    Spandidos DA, Pintzas A, Kakkanas A, Yiagnisis M, Mahera H, Patra E, Agnantis NJ.
    Anticancer Res; 1987 May 15; 7(6):1299-304. PubMed ID: 3327455
    [Abstract] [Full Text] [Related]

  • 19. Cytokeratin intermediate filament expression in benign and malignant breast disease.
    Heatley M, Maxwell P, Whiteside C, Toner P.
    J Clin Pathol; 1995 Jan 15; 48(1):26-32. PubMed ID: 7535804
    [Abstract] [Full Text] [Related]

  • 20. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
    Kaczmarek J, Castellani P, Nicolo G, Spina B, Allemanni G, Zardi L.
    Int J Cancer; 1994 Oct 01; 59(1):11-6. PubMed ID: 7927891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.